PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
22.57%
Similar revenue growth to CRWV's 23.55%. Walter Schloss would investigate if similar growth reflects similar quality.
No Data
No Data available this quarter, please select a different quarter.
22.57%
Similar gross profit growth to CRWV's 25.15%. Walter Schloss would investigate industry dynamics.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-247.92%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-220.68%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-247.92%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-220.68%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
247.92%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.26%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
3.26%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.